用户名: 密码: 验证码:
中医辨证治疗视神经萎缩的临床研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的
     观察中医辨证论治治疗视神经萎缩的临床疗效。
     方法
     对21例(34眼)视神经萎缩患者具体情况分为肝肾不足、气血不足、肝郁气滞、阴虚火旺四种证型,分别予以左归饮加减(补益肝肾)、八珍汤加减(补益气血)、丹栀逍遥散加减(疏肝理气)、知柏地黄汤加减(滋阴清热)进行治疗,在视力、视野、视觉诱发电位、视网膜断层扫描方面进行治疗前后的比较,并进行显效率、有效率的评价。
     结果
     1、在视力结果分析中,治疗前后差异有非常显著性意义p<0.01。其中13只眼视力提高2排以上,5只眼视力提高1排。
     2、在视野检查中,视敏感度及视野缺损的治疗前后差异无明显变化。
     3、在视觉诱发电位结果分析中,P100波潜伏期明显缩短p<0.02,波幅无显著性差异。
     4、在视网膜断层扫描方面结果分析中,视杯面积、C/D比值及盘沿面积前后治差异不显著(p>0.05);但是,视网膜神经纤维层厚度有明显提高。
     5、根据中医证型疗效分析,治疗好转有极显著性差异,总效率达73.53%。
     6、病程与治疗疗效的比较中,病程短高于病程较长,病程与疗效率成相对性。数据显示显著性差异有一定统计意义。
     结论
     中医辨证论治治疗各病因所导致的视神经萎缩的治疗方法具有较好的临床疗效,好转率达73.53%。在治疗前后分析视力及视觉诱发电位的潜时变化上有明显的差异,(p<0.02)。在视网膜断层扫描方面,虽然病例样本量少,在统计学上无意义,这里却证明视网膜纤维层厚度在治疗前后的比较有明显性的增生,说明该治疗方法具有保护视神经,提高患者视功能的作用,病程长短对治疗疗效有一定的影响。
Objective
     Clinical effectiveness of TCM differentiation treatment on various optic atrophy.
     Method
     21 cases consists of 34 eyes with various etiological classification of optic atrophy are divided according to their TCM symptomatic conditions into four categories based on deficiency of liver-kidney, deficiency of qi and blood, qi and liver stagnation as well as yin-deficiency and fire-excess types. The four categories were treated respectively with modified zuoguiyin (to nourish liver and kidney), modified bazhentang (to tonify qi and blood ), modified danzhixiaoyaosan (to regulate liver qi ) and modified zhibaidihuangtang (to nourish yin to clear pathogenic heat). Comparisons were done on data obtained before and after treatment. Statistical analysis were performed on data from visual acuity test, field analysis test, Visual Evoked Potential (VEP) and Heidelberg Retina Tomography (HRT).
     Results
     1. There is significant improvement in vision acuity between before and after treatment, p<0.01.
     2. Light sensitivity and visual defects remained almost constant.
     3. In the Visual Evoked Potential (VEP) analysis, it is found that P100 peak latency period has significantly reduced, p<0.02 after treatment, while amplitude remained unchanged.
     4. In Heidelberg Retina Tomography analysis, cup area, cup/disc ratio and rim area are of no significance improvement, p>0.05; however, retina nerve fiber layer thickness has shown a significant increase.
     5. Based on TCM treatment analysis, it is found that the overall effectiveness is 73.53%.
     6. There is an observed improvement in effectiveness of treatment for patients with shorter period of disease, however, it is statistically insignificant.
     Conclusion
     With TCM differentiation treatment on various types of optic atrophy, there is an observbed significant improvement in acuity (p<0.01) and a reduction in VEP latency period (p<0.02). Although sample collected was limited to reach a statistical conclusion on parameters done on HRT tests, it is observed that retina nerve fiber thickness increased by 5% as compared to before treatment. It is evident that TCM differentiation treatment has an impact on visual function protection and thus can improve its functionality.
引文
[1].韦介平(综述)1外伤性视神经病变的治疗[J]1中国中医眼科杂志,1995,1:571
    [2].Mayorov,V.,Biousse,V.,Newman,N.J.and Brown,M.D.(2005).The role of the ND5 gene in LHON:Characterization of a new,heteroplasmic LHON mutation.Annals of Neurology 58(5):807-811.
    [3].Zhadanov,S.I.,Atamanov,V.V.,Zhadanov,N.I.,Oleinikov,O.V.,Osipova,L.P.and Schurr,T.G.(2005).A novel mtDNA ND6 gene mutation associated with LHON in a Caucasian family.Biochemical and Biophysical Research Communications 332(4):1115-1121.
    [4].Fauser S.et al.Ophthalmic Genet,2002;23(30:191
    [5].Brown MD et al.Hum Genet,2001;109:33
    [6].Brown MD et al.Hum Genet,2002;110(2):130
    [7].Macmillan C et al.Am J.Hum Genet,2000;66;332
    [8].Nikoskelainen EK et al.Ophthalmology,1996;103:504
    [9].Nakamura M.et al.Br.J.Ophthalmology,2000;84:534
    [10].张承芬主编《眼底病学》人民卫生出版社,1998年1月第1版
    [11].Hayreh SS:Systemic arterial blood pressure and the eye.Eye 1996;10:1-24.
    [12].Hayreh SS.Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension.Curr Opin Ophthalmol 1999;10:474-82.
    [13].Hayreh SS,Podhajsky PA,Zimmerman B.Role of nocturnal arterial hypotension in optic nerve head ischemic disorders.Ophthalmologica 1999;213:76-96.
    [14].Hayreh SS,Podhajsky PA,Zimmerman B:Beta-Blocker eye drops and nocturnal arterial hypotension.Am J Ophthalmol 1999;128:301-9.
    [15].Hayreh SS,Zimmerman MB,Podhajsky P,Alward WLM.Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.Am J Ophthalmol 1994;117:603-24.
    [16].Hayreh SS.Posterior ischaemic optic neuropathy:clinical features,pathogenesis,and management.Eye,2004,18:1188-1206.
    [17].宋琛编著.《缺血性眼病治疗新概念》,人民军医出版社,2005年8月第一版
    [18].穆进军,李俊峰,田仁.急性甲醇中毒295例临床研究.中国工业医学杂志.2000:13(2):78.
    [19].杨红.砷制剂慢性中毒致双眼视神经萎缩.中国实用眼科杂志,1995;13(6):378.
    [20].李泽宇,郑宏君,韩萍,等.饮水型地方性砷中毒引起神经系统损害的临床观察及研究.中华神经科杂志,1998;31(2):95.
    [21].Rajdeep Chowdhury,Abhishek Dutta,Susri Ray Chaudhuri,Nilendu Sharma,AshokK.Girl and Keya Chaudhuri.In vitro and in vivo reduction of sodium arsenite induced toxicity by aqueous garlic extract.Food and Chemical Toxicology,2008;46(2):740-751
    [22].胡运韬,刘蔼年,刘海林.氟乙酰胺中毒致双日失明一例中华眼科杂志;1997;33(1):182.
    [23].姚大庆.有机磷农药中毒性视神经萎缩二例.中华眼科杂志,1997;33(3):197.
    [24].孙翠荣,朱朝霞.有机磷农药致中毒性视神经萎缩2例.临床眼科杂志,200l;9(5):395.
    [25].穆爱君,贾玉东.有机磷中毒致双眼视神经萎缩.中国实州眼科杂志.2002.20(1):605.
    [26].穆爱君,贾玉东.有机磷中毒致双眼视神经萎缩一例.眼外伤职业眼病杂志.2002;24(1):45.
    [27].陈明.抗结核药物致盲1例.中原医刊,1999;23(4):18-21.
    [28].李儒珍.口服乙胺丁醇治疗肺结核致视神经萎缩3例报告.中国中医眼科杂志,1999;2(3):49.
    [29].胡园菊.药物中毒性视神经萎缩一例报告,眼外伤职业眼病杂志,2002;24(2):200
    [30].李智君.江琳,乙胺丁醇致双眼视神经萎缩1例.Anthology of Medicine,2000.4(19):2
    [31].温建华,郑立军,李素惠,金芳.胞二磷胆碱联合碟脉灵治疗乙胺丁醇中毒性视神经病变的临床探讨.潍坊医学院学报.2005,27(5):346
    [32].刘红梅,刘伟军,胡沛全.肌肉注射链霉素引起角膜炎1例[J].中华眼科杂志,1999,35(1):28.
    [33].惠瑜,陈瑞生.糖皮质激素性高眼压43例临床分析[J].陕西医学杂志,2004,33(5):461.
    [32].刘红梅,刘伟军,胡沛仝.肌肉注射链霉素引起角膜炎1例[J].中华眼科杂志,1999,35(1):28.
    [33].惠瑜,陈瑞生.糖皮质激素性高眼压43例临床分析[J].陕西医学杂志,2004,33(5):461.
    [34].M(u|¨)ller H.Antomische beitrage zur Ophthalmologie;ueber nervean-veranderungen an der eintrittsstelle des schnerven.Arch.Ophthalmol,1858,4:1
    [35].von Jaeger E.Ueber glaucoma und seine heilung durch iridectomid.Z Ges der Aertze zuu Wien,1858,14:465,484
    [36].葛坚.我国近五年青光眼临床与基础研究进展[J].中华眼科杂志,2005,41,(8):710-716
    [37].徐亮.识别早期青光眼视神经损害的新概念[J].眼科,2003,12,(6):324-326
    [38].Calandrella N.,Scarsella G.,Pescosolido N.,Risuleo G.,Degenerative and apoptotic events at retinal and optic nerve level after experimental induction of ocular hypertension.[J].MolCellBiochem,2007,301(1):155-163
    [39].Hayreh SS.Diabetic papillopathy and nonarteritic anterior ishemic optic neuropathy.Surv Ophthalmol 2002;47:600-2.
    [40].Medlej R,Wasson J,Baz P,etal.Diabetes mellitus and optic atrophy:a study of Wolfram syndrome in the Lebanese population.2004;89(4):1656- 1661.
    [41].Bernstein SL,Guo Y,Kelman SE,Flower RW,Johnson MA.Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy.Invest Ophthalmol Vis Sci 2003;44(10):4153-4162.
    [42].Bernstein SL,Guo Y,Slater BJ,Puche A,Kelman SE.Neuron stress and loss following rodent anterior ischemic optic neuropathy in double reporter transgenic mice.Invest Ophthalmol Vis Sci 2007;48:2304-2310.
    [43].Bernstein SL,Koo JH,Slater BJ,Guo Y,Margolis FL.Analysis of optic nerve stroke by retinal Bex expression.Mol Vis 2006.12,147-155.
    [44].Goldenberg-Cohen N,Guo Y,Margolis FL,Miller NM,Cohen Y,Bernstein SL.Oligodendrocyte Dysfunction Following Induction of Experimental Anterior Optic Nerve Ischemia.Invest Ophthalmol Vis Sci 2005.46,2716-2725.
    [45].Bernstein SL,Mehrabian Z,Guo Y,Moianie N.Estrogen is not neuroprotective in a rodent model of optic nerve stroke.Molecular Vision 2007;13:1920-1925.
    [46].中国人民解放军总后勤部卫生部.临床疾病诊断依据治愈好转标准.第二版.北京:人民军医出版社 2006.
    [47].国家中医药管理局.中医病证诊断疗效标准.南京:南京大学出版社1994.
    [48].刘杏,梁远波,凌运兰等.视网膜断层扫描仪在青光眼性视神经病变中的诊断价值[J]中华眼科杂志,2004,40(11):737
    [49].杜力,图像反转视觉诱发电位(第一部分:正常眼所见).眼科研究,1993,24(4):47
    [50].沈克艰.针刺治疗近视眼前后视觉诱发电位影响.江西中医药,1993,24(4):47
    [51].李建东.图形视觉诱发电位与屈光不正之关系.实用眼科杂志,1988,6(6):338
    [1].张秀丽.复方樟柳碱治疗外伤性视神经萎缩临床疗效观察[J].中国煤炭工业医学杂志,2007,10(2):183
    [2].张海龙.复方樟柳碱注射液治疗视网膜视神经疾病疗效分析[J].中原医刊,2006,33(18):76
    [3].凌国英,张幼丽,周文璇.颞浅动脉旁皮下注射复方樟柳碱治疗视神经萎缩的探讨[J].上海护理,2006,6(6):28
    [4].张宝勤,赵剑虹.复方樟柳碱对外伤性视神经病变的疗效分析[J].基层医学论坛,2006,10(4A):296
    [5].齐翠英.益精活血通窍汤治疗视神经萎缩临床观察[J].中国中医药信息杂志,2004,11(10):914
    [6].张萍.活血化瘀法治疗视神经萎缩50例临床观察[J].中国民康医学,2007,19(9):767
    [7].王凤利,张娓.活血通脉复明汤治疗视神经萎缩[J].现代中西医结合杂志,2004,13(17):2313
    [8].李巧凤.疏柔明目汤为主治疗视神经萎缩76例[J].四川中医,2004,22(10):88
    [9].李景贵.通补兼治视神经萎缩的体会[J].辽宁中医杂志,2004,31(7):585
    [10].罗辉红,朱惠安.中药治疗前部缺血性视神经病变临床观察[J].中国中医眼科杂志,2004,14(3):152
    [11].高培质.益气养血通络法治疗缺血性视神经病变[J].中国中医眼科杂志,2004,14(2):97
    [12].罗秀梅,李红珏,车月玖,庞荣.归脾汤辨证治疗视神经萎缩临床研究[J].河北中医,2004,26(7):541
    [13].马冰松,马雪松,芦苇.综合疗法治疗视神经萎缩28例分析[J].中医药学刊,2004,22(1):169
    [14].罗平,刘爱英,张淑忆.针刺配合中药治疗视神经萎缩36例[J].中国针灸,2005,25(7):504
    [15].庞荣.补气养血解郁汤治疗视神经萎缩35例临床观察[J].河北中医药学报,2004,19(1):19
    [16].姜健丽,曾红艳.葛根素注射液,血府逐瘀汤加减,针灸穴注并用治疗视神经萎缩50例临床观察[J].中国中医药科技,2005,12(1):51
    [17].孙慧悦.针药结合治疗视神经萎缩36例58眼[J].辽宁中医杂志,2007,34(3):330
    [18].孙河,王玉斌,针药并用治疗外伤性视神经萎缩13例[J].针灸临床杂志,2007,23(6):11
    [19].王兴刚,综合疗法治疗视神经萎缩疗效观察[J].牡丹江医学院学报,2006,27(1):35
    [20].田永远.中西医结合治疗视神经萎缩32例[J].河南中医,2007,27(7):54
    [21].秦祖杰,郝小波.五联总攻疗法治疗视神经萎缩61例分析[J].四川中医,2005,23(10):97
    [22].周星海.中西医结合治疗视神经萎缩126例[J].现代中西医结合杂志,2006,15(23):3221
    [23].齐萍,周冬梅.复方樟柳碱治疗外伤性视神经萎缩的临床观察[J].中国实用中医药.2007,2(19):95
    [24].郝进.复方樟柳碱治疗眼前部缺血性视神经病变52例[J].临床眼科杂志,2005,13(3):264
    [25].谢艳君,谢康明.中西医结合治疗视神经萎缩58例体会[J].中医药导报,2006,12(8):63
    [26].苗富来.中西医结合治疗视神经萎缩22例[J].天津中医药,2006,23(2):97
    [27].冯英,王明英.复方丹参及葛根素注射液治疗缺血性眼病疗效观察[J].医学检验与临床,2006,17(6):86
    [28].李文俊,余良智,张梅.中药疏肝明目丸治疗视神经萎缩129例[J].国际眼科杂志,2004,4(1):186
    [29].马传民,王丽英,公玉琴,吴文忠.中西医结合治疗视神经萎缩的临床探讨[J].牡丹江医学院学报,2005,26(6):36
    [30].徐恒光,殷善开,程印涛,段中宁.视神经减压术在治疗视神经萎缩中的应用[J].临床耳鼻咽喉科杂志,2005,19(24):1136
    [31].王志军,龚晓莉.经皮中药离子导入治疗视神经萎缩的临床研究[J].甘肃中医学院学报,2006,23(1):31
    [32].黄丽香,张明珍,林小红.高压氧治疗视神经萎缩8例报道[J].福建医药杂志,2006,28(4):173

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700